K
Kaden Health
A behavioral health company dedicated to solving the greatest healthcare challenges of time
About Kaden Health
Kaden Health operates as a data-driven, digital behavioral health company with a sharp focus on tackling the opioid addiction crisis in the United States. Founded in 2018 and headquartered in New York City, the firm was established to address significant healthcare challenges by merging technology with a human-centric approach to care. The company's founders include Dave Henderson, who served as CEO, and Aran Ron, M.D., who was the Head of Clinical Innovation. On December 5, 2021, Kaden Health was acquired by BayMark Health Services, a national leader in substance use disorder treatment, to enhance and expand its telemedicine services.
The company targets the growing Opioid Use Disorder (OUD) market, which was estimated at $2.8 billion in 2022 and is projected to expand significantly. Kaden's business model centers on its proprietary Virtual Medication-Assisted Treatment (vMAT) platform. This service is designed for individuals suffering from OUD, providing them with virtual access to care after an initial in-person medical evaluation. Revenue is generated by providing its comprehensive telehealth program to patients, members, and customers of healthcare providers and organizations. The company also makes its HIPAA-compliant platform available as a stand-alone solution for providers. Prior to its acquisition, Kaden Health had raised a total of $19.1 million in funding.
Kaden's core service is a fully integrated vMAT program that delivers the clinical standard of care for OUD virtually. The Kaden Technology Platform serves as the central interface connecting the patient, therapist, medical prescriber, and a dedicated patient advocate. This allows for collaborative and continuous communication among all parties involved in the patient's recovery. Key features include virtual medical and therapy appointments accessible via smartphone, tablet, or PC, weekly virtual group therapy, and daily therapist outreach. A notable aspect of the technology is its use of artificial intelligence, which analyzes facial and voice data to provide real-time insights into a patient's emotional state, such as changes in anxiety or stress levels. This integrated system is designed to improve accessibility, convenience, and long-term treatment effectiveness compared to traditional methods.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Nov 2020 | $19M | $76M | Undisclosed | — |
Growth signals
Latest recorded traffic for Kaden Health is 130 monthly website visits, down 98.5% over the last three months. Kaden Health's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Kaden Health in the New York City ecosystem
The Kaden Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kaden Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kaden Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









